首页> 外文OA文献 >Removal of N-terminal methionine from recombinant proteins by engineered E. coli methionine aminopeptidase
【2h】

Removal of N-terminal methionine from recombinant proteins by engineered E. coli methionine aminopeptidase

机译:通过工程化的大肠杆菌蛋氨酸氨肽酶从重组蛋白中去除N末端蛋氨酸

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The removal of N-terminal translation initiator Met by methionine aminopeptidase (MetAP) is often crucial for the function and stability of proteins. On the basis of crystal structure and sequence alignment of MetAPs, we have engineered Escherichia coli MetAP by the mutation of three residues, Y168G, M206T, Q233G, in the substrate-binding pocket. Our engineered MetAPs are able to remove the Met from bulky or acidic penultimate residues, such as Met, His, Asp, Asn, Glu, Gln, Leu, Ile, Tyr, and Trp, as well as from small residues. The penultimate residue, the second residue after Met, was further removed if the antepenultimate residue, the third residue after Met, was small. By the coexpression of engineered MetAP in E. coli through the same or a separate vector, we have successfully produced recombinant proteins possessing an innate N terminus, such as onconase, an antitumor ribonuclease from the frog Rana pipiens. The N-terminal pyroglutamate of recombinant onconase is critical for its structural integrity, catalytic activity, and cyto-toxicity. On the basis of N-terminal sequence information in the protein database, 85%–90% of recombinant proteins should be produced in authentic form by our engineered MetAPs.
机译:蛋氨酸氨基肽酶(MetAP)去除N末端翻译引发剂Met通常对于蛋白质的功能和稳定性至关重要。根据MetAP的晶体结构和序列比对,我们通过底物结合口袋中的三个残基Y168G,M206T,Q233G的突变设计了大肠埃希菌MetAP。我们精心设计的MetAP能够从庞大或酸性的倒数第二个残基(例如Met,His,Asp,Asn,Glu,Gln,Leu,Ile,Tyr和Trp)以及少量残基中去除Met。如果倒数第二个残基(Met之后的第三个残基)很小,则进一步去除倒数第二个残基(Met之后的第二个残基)。通过在大肠杆菌中通过相同或单独的载体共表达工程化的MetAP,我们已经成功地生产了具有先天N末端的重组蛋白,例如onconase,一种来自青蛙Rpi pipiens的抗肿瘤核糖核酸酶。重组onconase的N端焦谷氨酸对其结构完整性,催化活性和细胞毒性至关重要。根据蛋白质数据库中N端序列的信息,我们的工程MetAP应以真实的形式生产85%–90%的重组蛋白质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号